ClinicalTrials.Veeva

Menu

Prophylactic Negative Wound Pressure Therapy (PICO-7) Following Groin Incisions in Vascular Surgery (PICO-Vasc Study)

C

Corporacion Parc Tauli

Status

Enrolling

Conditions

Surgical Wound Infection

Treatments

Other: Prophylactic Negative Pressure Dressing
Other: Regular waterproof sterile dressing.

Study type

Interventional

Funder types

Other

Identifiers

NCT04840576
TauliCV002

Details and patient eligibility

About

Comparison between waterproof sterile dressing OPSITE Post-Op Visible, Smith & Nephew, UK and PICO-7, Smith & Nephew, UK in terms of inguinal surgical wound infection and complications after lower limb revascularization.

Full description

Patients will follow a preoperative preparation:

  • Routine pre-surgical skin hygiene with soap or antiseptic agent
  • Groin shaving with a machine
  • Preoperative antibiotic prophylaxis with cefazolin 2 gr ev. single dose or clindamycin 900 mg ev. in case of allergy to beta-lactams 30 min before the start of the intervention. In case of prolongation of the intervention (> 4h), a second antibiotic dose will be administered
  • Surgical field antisepsis using a sterile swab soaked in 2% chlorhexidine solution in 70% isopropyl alcohol, except for contraindications (such as potential contact with mucosa or open wounds, in which case 10% povidone-iodine solution will be used); usual sizing.

At the end of the revascularization surgical procedure, the inguinal wound will be closed using 2-0 or 3-0 Vicryl subcutaneous absorbable suture (Ethicon Inc, Somerville, NJ, USA) in two independent planes and skin closure with metal staples (B / Braun Manipler® AZ). The opaque randomization result allocation envelope will then be opened and the surgical area nurse will cover the wound with one of the two assigned dressings:

  • Group 1 (intervention group): The surgical wound will be covered in a sterile manner with prophylactic TPN (PICO-7, Smith & Nephew, UK).
  • Group 2 (control group): The surgical wound will be covered in a sterile way with the usual dressing (waterproof sterile dressing OPSITE Post-Op Visible, Smith & Nephew, UK).

During admission, regular follow-up will be carried out. On the 7th day, the dressings of both groups will be lifted. From this moment, if the wound allows it, air healing will be carried out without new dressings. After discharge from the hospital, the surgical wound evaluation will be carried out by the nurse responsible for Outpatient Consultations at 14 and 30 days postoperatively.

Enrollment

132 estimated patients

Sex

All

Ages

18 to 95 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age: 18-90
  • Undergoing elective revascularization surgery (Rutherford clinical categories 4-6 / Fontaine III and IV) requiring a longitudinal inguinal approach (a longitudinal inguinal incision is defined as the one that runs from the inguinal ligament to the femoral bifurcation, performed with the intention of approaching the vascular bundle).
  • Surgery performed by investigator and co-investigators: Vascular Surgeons of the Vascular Surgery Department at the Parc Taulí Hospital.
  • Patients must be able to understand the study and sign the specific informed consent before surgery.

Exclusion criteria

  • Urgent surgery
  • Interventions in which transverse groin wounds.
  • Presence of active groin infection that prevents primary closure
  • Pediatric patients, pregnant women or patients with impaired higher functions who cannot understand the study or collaborate with its protocolized follow-up.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

132 participants in 2 patient groups, including a placebo group

Conventional Dressing
Placebo Comparator group
Description:
waterproof sterile dressing OPSITE Post-Op Visible, Smith \& Nephew, UK
Treatment:
Other: Regular waterproof sterile dressing.
Prophylactic negative wound pressure dressing
Experimental group
Description:
PICO-7, Smith \& Nephew, UK
Treatment:
Other: Prophylactic Negative Pressure Dressing

Trial contacts and locations

1

Loading...

Central trial contact

Kerbi A Guevara Noriega, MD MSc PhD; Laura M Rodriguez, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems